FDA grants AP status for Simvastatin ANDA076685 by Watson Labs Teva
The FDA has granted approval status (AP) for the Abbreviated New Drug Application (ANDA076685) for Simvastatin submitted by Watson Labs Teva.
Asset / Drug
Drug and asset intelligence for Simvastatin with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.